Company Filing History:
Years Active: 1987
Title: The Innovations of George D. Meakins
Introduction
George D. Meakins is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that exhibit beta-adrenoceptor antagonist activity. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
One of George D. Meakins' key patents is titled "Pharmaceutical compositions having .beta.-adrenoceptor antagonist." This invention relates to isopropyl and tertiary butyl-amino-2-hydroxypropoxyphenyl-3[2H]-pyridazinones, which are compounds that demonstrate beta-adrenoceptor antagonist activity. This patent highlights his expertise in pharmaceutical chemistry and his commitment to advancing medical science.
Career Highlights
George D. Meakins is associated with Smith Kline & French Laboratories Limited, a company known for its research and development in the pharmaceutical industry. His role at this esteemed organization has allowed him to contribute to significant advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, George D. Meakins has collaborated with notable colleagues, including Anthony Maitland Roe and William J. Coates. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceuticals.
Conclusion
George D. Meakins exemplifies the spirit of innovation in the pharmaceutical industry through his patent and collaborative efforts. His work continues to influence the development of important medical therapies, underscoring the vital role of inventors in advancing healthcare solutions.